echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > Trials show that AI guidance can help early detection of heart disease in routine practice

    Trials show that AI guidance can help early detection of heart disease in routine practice

    • Last Update: 2021-05-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Trials show that AI guidance can help early detection of heart disease in routine practice
    Trials have shown that AI guidance can help early detection of heart disease in routine practice Trials have shown that AI guidance can help early detection of heart disease in routine practice

    Certain types of heart disease may be difficult to detect, such as asymptomatic low ejection fraction, especially in the early stages when treatment is most effective.


    A low systolic ejection fraction is defined as the inability of the heart to contract strongly enough at each beat to draw at least 50% of the blood from its chambers.


    The EAGLE trial was conducted in 45 medical institutions in Minnesota and Wisconsin, including rural clinics, community, and academic medical centers.


    "AI-supported ECG can identify patients who may have been missed before, and help diagnose patients with low ejection fraction in reality.


    Within 8 months, 22,641 adult patients underwent ECG under the care of the clinician in the trial.


    “Compared with conventional care, AI intervention has increased the overall diagnosis rate of low ejection fraction by 32%.


    "With EAGLE, this information can be obtained in the electronic medical record at any time, and the nursing team can see the results and decide how to use the information," Dr.


    In addition, the EAGLE trial used a positive bias method to evaluate the top five nursing team users and the top five non-users of AI screening information.


    EAGLE is one of the first large-scale experiments to prove the value of AI in routine practice.


    The EAGLE trial was funded by the Robert D.


    )

    Related paper information: org/10.


    org/10.
    1038/s41591-021-01335-4" target="_blank">https://doi.
    org/10.
    1038/s41591-021-01335-4
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.